SK Chemicals signs exclusive supply agreement of Parkinson’s treatment with Portuguese BIAL
SK Chemicals will supply treatments for Parkinson’s disease patients with motor fluctuation in Korea.
SK Chemicals announced on the 5th that the company has signed a license agreement of exclusive supply of ‘Ongentys(generic name: opicapone)’ in Korea with the largest Portuguese pharmaceutical c...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
